Showing posts with label pancreatic cancer risk factors. Show all posts
Showing posts with label pancreatic cancer risk factors. Show all posts

Saturday, November 5, 2011

May Aspirin Lower Pancreatic Cancer Risk?


Aspirin is the pain killer of choice of many Americans and is also recommended by a number of health care providers to reduce the risk of heart disease. Results of a new study reveal that tablet may also play a role in pancreatic cancer prevention in addition to having heart health benefits and providing pain relief.

Aspirin belongs to a class of medications known as non-steroidal anti-inflammatory drugs (NSAIDs). Aspirin, like other NSAIDs, blocks a key enzyme that leads to inflammation in our bodies. This enzyme, cyclooxygenase, is also known to play an important role in the development of several types of cancer, and so aspirin, and other NSAIDs, have been extensively studied as potential cancer prevention drugs.

A recent study conducted by researchers from the Mayo Clinic College in Minnesota compared the use of pain relievers in more than 2000 adults age 55 and over. Researchers were able to conclude from the information gathered that subjects who took aspirin regularly were at a reduced risk of developing pancreatic cancer.

People who took aspirin at least once a month were 29% less likely to develop pancreatic cancer than those who used other types of pain relievers or nothing at all. Researchers also found people who regularly take low-dose aspirin to reduce their risk of heart disease had a 35% lower risk of pancreatic cancer. These very impressive results were evident even after researchers factored in other risks for pancreatic cancer, such as body mass index (BMI) and smoking status.

The researchers did not see a benefit from non-aspirin NSAIDs or acetaminophen. "This provides additional evidence that aspirin may have chemoprevention activity against pancreatic cancer," said Xiang-Lin Tan, Ph.D., M.D., a research fellow at Mayo Clinic in Rochester, Minn. He added that more data must be gathered.

Why Aspirin?

"This study just looked at an association," Dr. Jennifer Ashton said. "So it did not provide cause-and-effect or the mechanism. But there is a theory that the way that aspirin and drugs like Motrin or Advil work to reduce other types of cancer risk is by cutting the risk of inflammation. Now, interestingly in this study, they also found a slight reduction in risk amongst those healthy people who took ibuprofen, but it just wasn't statistically significant. So again, the thinking is that it cuts down on inflammation."

So should you start taking aspirin as a precaution?

Dr. Ashton warned that people need to understand the risks -- just like with any other drug. "Some doctors say that, if aspirin went up for (Food and Drug Administration) approval as an over-the-counter medication today, it may not get approved so readily," she said.

Ashton warned aspirin can increase the risk of gastrointestinal bleeding, as well as stomach irritation, and can worsen asthma. Aspirin, most importantly, she said, can interact with other drugs, and especially blood thinners.  "It definitely has risks, and people should talk to their doctor about whether those are worth it," Ashton said.

Other Studies

While a randomized, placebo-controlled, prospective clinical research trial will be necessary to confirm the encouraging findings of this latest clinical research study, the findings of this case control study are, nonetheless, very compelling. Moreover, the findings of this retrospective study are very similar to the findings of both retrospective and prospective clinical research studies that have previously identified a similar reduction in the risk of colorectal cancer with aspirin and other NSAIDs.

However, not all the researchers reported the similar results as outcomes of the previous studies.

 In this 2002 hospital-based case-control study, 194 patients with pancreatic cancer were compared to 582 age and sex-matched patients with non-neoplastic conditions to examine the association between aspirin use and risk of pancreatic cancer at the Roswell Park Cancer Institute in Buffalo, NY. It was reported that pancreatic cancer risk in aspirin users was not changed relative to non-users. No significant change in risk was found in relation to greater frequency or prolonged duration of use, in the total sample or in either gender. Therefore, the outcomes suggested that regular aspirin use may not be associated with lower risk of pancreatic cancer.

Even more unexpected results were received by so called Nurses Study. An analysis of data from the Nurses' Health Study, published in the Jan. 7, 2004 issue of the Journal of the National Cancer Institute, suggested that regular use of aspirin for 20 years or more is associated with an increased risk of pancreatic cancer.The study of 88,000 nurses found that those who took two or more aspirins a week for 20 years or more had significantly higher risk of pancreatic cancer.

In details, who had reported regular aspirin use for more than 20 years were more likely to develop the cancer than women who hadn’t taken aspirin.
  • 86% increased risk 14 or more tablets per week
  • 41% increased risk 6 to 13 tablets per week
  • 29% increased risk 4 to 6 tablets per week
  • 11% increased risk 1 to 3 tablets per week

"Apart from smoking, this is one of the few risk factors that have been identified for pancreatic cancer," Dr. Eva Schernhammer of Harvard Medical School and Brigham and Women's Hospital in Boston, who led the study, told a news conference.

"Initially we expected that aspirin would protect against pancreatic cancer, especially since its preventive role in colorectal cancer has been well documented. However, now it appears that we need to examine the relationship more thoroughly," Schernhammer added in a statement.

Summary

Because these substantial differences from findings in different studies, I would suggest do not take a side on any of the conclusions yet, but wait and see more elaborated studies’ results. It is however obvious that there are no easy answers, and that the conflict should be an impetus to additional research. Also, by no mean you should not stop using aspirin, as there are still important proven benefits to the drug.

However, the solid answer to the question of the aspirin’s ability to prevent pancreatic cancer is yet to be provided by ongoing medical researchers.


Sources and Additional Information:




Sunday, July 10, 2011

Dental Problems Linked to Increased Risk of Pancreatic Cancer


In January 2007, a group of Harvard investigators published some research suggesting that periodontal disease—as a marker of a susceptible immune system—may indicate an increased risk for pancreatic cancer.

Investigation of this possible association is still ongoing, but preliminarily it appears that periodontal disease and pancreatic cancer may be linked by an underlying mechanism that is inflammatory driven. An understanding of this potential relationship may help dental practitioners to better educate their patients on the potential ramifications of systemic inflammation in the oral cavity relative to diseases of the digestive tract.

Encouraged by previous studies that suggests gum inflammation (periodontal disease) and tooth loss may also be associated in some way with an increased risk of pancreatic cancer, researchers from Harvard University and the University of Puerto Rico looked at a large database of information to find out whether there was any evidence of such a connection.

In 16-year, questionnaire-based, study of 51,529 predominately Caucasian male health professionals between ages 40 and 75, 216 men were diagnosed with pancreatic cancer. Researchers reported that periodontal disease was associated with a 64% increase in the risk of pancreatic cancer, after adjusting for smoking and other risk factors. The researchers also found that within this study population, periodontal disease with recent tooth loss (within the previous four years) was associated with a 2.7-fold increase in the risk of pancreatic cancer. Furthermore, they found that the timing and severity of periodontal disease, as manifested by recent tooth loss, may have a joint effect.

Age, smoking, and obesity did not appear to influence the association between periodontal disease and pancreatic cancer. When men with a history of diabetes were excluded from the analysis, a statistically significant association between periodontal disease and pancreatic cancer was still observed. The investigators suggested that several mechanisms may explain the biological plausibility of the associations observed in this study.

Possible Explanations

One of the hypotheses of why the dental problems might be a substantial risk factor for the pancreatic cancer development is that periodontal disease may promote pancreatic carcinogenesis through inflammation. The investigators cite earlier reports that plasma C-reactive protein (CRP) levels—an important biomarker of systemic inflammation—were consistently higher in subjects with a history of periodontal disease than those with no history.

"People with periodontal disease have higher levels of blood levels of C-reactive protein, an inflammatory marker that has been associated with heart disease," noted Dominique S. Michaud, an assistant professor of epidemiology at the Harvard School of Public Health in Boston. "Periodontal disease is also linked to heart disease in some studies." The inflammation may somehow contribute to the promotion of cancer cells, she added.

An alternative hypothesis is that periodontal disease may influence pancreatic carcinogenesis through increased generation of ­carcinogens, specifically nitrosamines. Nitro­samines are known to induce pancreatic cancer in animals and are considered potential carcinogens in human pancreatic cancer. Approximately 45% to 75% of nitrosamine formation is endogenously formed by salivary and gastrointestinal bacteria. The formation of nitrosamines in the oral cavity of individuals with poor oral hygiene is eight times higher than in individuals with good oral hygiene.  Also, periodontal disease and poor oral hygiene are associated with higher levels of oral bacteria and elevated nitrosamine levels within the oral cavity. As such, this relationship may place certain individuals at greater risk because nitrosamines and gastric acidity may play important roles in pancreatic cancer.

Individuals afflicted with chronic pancreatitis are at greater risk for developing pancreatic adenocarcinoma. Research published by Wheatley-Price and colleagues suggests that inflammation plays a role in the disease etiology of pancreatic cancer through the different forms of several inflammatory pathway genes. The same genotype is associated with an increased risk of coronary artery disease, raising the possibility that inflammatory processes may be important etiologically in pancreatic cancer. Accordingly, the chronic, low level inflammation associated with periodontitis may convey a greater risk of pancreatic cancer.

Stolzenberg-Solomon and colleagues examined the association between dentition history and pancreatic cancer on a prospective group of 29,133 Finnish men who smoked. They found that tooth loss was significantly associated with pancreatic cancer and that this trend was consistent across all categories of tooth loss. The researchers also reported that compared with those with less tooth loss, the edentulous subjects were more likely to have ulcers, which is linked to Helicobacter pylori infection.

Stolzenberg-Solomon and colleagues  discussed several mechanisms that may explain the increased risk associated with tooth loss and pancreatic cancer, including the contribution of poor oral hygiene to more deleterious gastrointestinal flora, and consequently, increased nitrosation. Another theory raised by these researchers is that tooth loss may be an indicator of a less healthy lifestyle or of health status in general. For instance, tooth loss reduces masticatory ability thereby leading to consuming a less healthy diet. Edentulous individuals in the study had greater intake of total and saturated fat and diminished intake of folate, both dietary factors that are associated with a greater risk of pancreatic cancer. The analysis of the data controlled for these dietary factors and the factors did not modify the association that Stolzenberg-Solomon and colleagues found between tooth loss and pancreatic cancer.

What Causes Periodontal Disease?

Our mouths are full of bacteria. These bacteria, along with mucus and other particles, constantly form a sticky, colorless "plaque" on teeth. Brushing and flossing help get rid of plaque.  Plaque that is not removed can harden and form "tartar" that brushing doesn't clean.  Only a professional cleaning by a dentist or dental hygienist can remove tartar.

The longer plaque and tartar are on teeth, the more harmful they become. The bacteria cause inflammation of the gums that is called "gingivitis."  In gingivitis, the gums become red, swollen and can bleed easily.  Gingivitis is a mild form of gum disease that can usually be reversed with daily brushing and flossing, and regular cleaning by a dentist or dental hygienist. This form of gum disease does not include any loss of bone and tissue that hold teeth in place.

When gingivitis is not treated, it can advance to "periodontitis" (which means "inflammation around the tooth.")  In periodontitis, gums pull away from the teeth and form spaces (called "pockets") that become infected. The body's immune system fights the bacteria as the plaque spreads and grows below the gum line. Bacterial toxins and the body's natural response to infection start to break down the bone and connective tissue that hold teeth in place. If not treated, the bones, gums, and tissue that support the teeth are destroyed.  The teeth may eventually become loose and have to be removed.   

Daily Oral Hygiene Measures to Prevent Periodontal Disease

  • Brushing properly on a regular basis (2 times a day), with the patient attempting to direct the toothbrush bristles underneath the gum-line, so as to help disrupt the bacterial and plaque growth that may occur there.
  • Use fluoride toothpaste. Using toothpaste with fluoride helps to prevent decay.
  • Flossing daily and using interdental brushes if there is sufficient space between teeth and behind the last tooth in each quarter.
  • There are some instances that typical brushing is not just enough. There are still some parts of your gums as well as oral cavity that are left non-brushed. In a typical dental consultation, you will be advised to use an electric toothbrush that will provide you with perfect cleaning angle for your teeth. In using this type of toothbrush, you will first feel some pain or discomfort. In most cases, your gums might bleed also. So in using this, you have to set the time, for example, 30 seconds first then gradually increase it when you can already tolerate the after brushing effects.
  • Using an antiseptic mouthwash. Chlorhexidine gluconate based mouthwash or hydrogen peroxide in combination with careful oral hygiene may cure gingivitis, although they cannot reverse any bone loss due to periodontitis. (Alcohol based mouthwashes may aggravate the condition).
  • Regular dental check-ups and professional teeth cleaning as required. Dental check-ups serve to monitor the person's oral hygiene methods and levels of bone around teeth, identify any early signs of periodontitis, and monitor if it has responded to treatment.


Sources and Additional Information:





Related Posts Plugin for WordPress, Blogger...